No abstract available
MeSH terms
-
Antineoplastic Agents* / adverse effects
-
Antineoplastic Agents* / therapeutic use
-
Drug Approval
-
Drug Discovery*
-
Humans
-
Medical Oncology*
-
Nitriles
-
Outcome Assessment, Health Care*
-
Patient Participation
-
Patient-Centered Care*
-
Pyrazoles / therapeutic use
-
Pyrimidines
-
United States
-
United States Food and Drug Administration
Substances
-
Antineoplastic Agents
-
Nitriles
-
Pyrazoles
-
Pyrimidines
-
ruxolitinib